848 related articles for article (PubMed ID: 26686393)
1. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
2. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic potential of purinergic signalling.
Burnstock G
Biochem Pharmacol; 2018 May; 151():157-165. PubMed ID: 28735873
[TBL] [Abstract][Full Text] [Related]
4. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
5. In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors.
Salmaso V; Jacobson KA
Biomolecules; 2020 May; 10(6):. PubMed ID: 32466404
[TBL] [Abstract][Full Text] [Related]
6. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
Jacobson KA; IJzerman AP; Müller CE
Biochem Pharmacol; 2021 May; 187():114311. PubMed ID: 33130128
[TBL] [Abstract][Full Text] [Related]
7. New paradigms in purinergic receptor ligand discovery.
Jacobson KA; Pradhan B; Wen Z; Pramanik A
Neuropharmacology; 2023 Jun; 230():109503. PubMed ID: 36921890
[TBL] [Abstract][Full Text] [Related]
8. Molecular structure and function of P2X receptors.
Habermacher C; Dunning K; Chataigneau T; Grutter T
Neuropharmacology; 2016 May; 104():18-30. PubMed ID: 26231831
[TBL] [Abstract][Full Text] [Related]
9. Would calcium or potassium channels be responsible for cardiac arrest produced by adenosine and ATP in the right atria of Wistar rats?
Camara H; Rodrigues JQ; Alves GA; da Silva Junior ED; Caricati-Neto A; Garcia AG; Jurkiewicz A
Eur J Pharmacol; 2015 Dec; 768():199-206. PubMed ID: 26528795
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Role of N
Petrelli R; Scortichini M; Kachler S; Boccella S; Cerchia C; Torquati I; Del Bello F; Salvemini D; Novellino E; Luongo L; Maione S; Jacobson KA; Lavecchia A; Klotz KN; Cappellacci L
J Med Chem; 2017 May; 60(10):4327-4341. PubMed ID: 28447789
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology and structure of P2Y receptors.
von Kügelgen I; Hoffmann K
Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
[TBL] [Abstract][Full Text] [Related]
12. P2X and P2Y nucleotide receptors as targets in cardiovascular disease.
Kennedy C; Chootip K; Mitchell C; Syed NI; Tengah A
Future Med Chem; 2013 Mar; 5(4):431-49. PubMed ID: 23495690
[TBL] [Abstract][Full Text] [Related]
13. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
14. Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.
Jacobson KA
J Med Chem; 2013 May; 56(10):3749-67. PubMed ID: 23597047
[TBL] [Abstract][Full Text] [Related]
15. The P2Y/P2X divide: How it began.
Kennedy C
Biochem Pharmacol; 2021 May; 187():114408. PubMed ID: 33444568
[TBL] [Abstract][Full Text] [Related]
16. Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms.
Jespers W; Schiedel AC; Heitman LH; Cooke RM; Kleene L; van Westen GJP; Gloriam DE; Müller CE; Sotelo E; Gutiérrez-de-Terán H
Trends Pharmacol Sci; 2018 Jan; 39(1):75-89. PubMed ID: 29203139
[TBL] [Abstract][Full Text] [Related]
17. Tools and drugs for uracil nucleotide-activated P2Y receptors.
Rafehi M; Müller CE
Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
[TBL] [Abstract][Full Text] [Related]
18. John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors.
Jacobson KA; Gao ZG; Paoletta S; Kiselev E; Chakraborty S; Jayasekara PS; Balasubramanian R; Tosh DK
Comput Struct Biotechnol J; 2015; 13():286-98. PubMed ID: 25973142
[TBL] [Abstract][Full Text] [Related]
19. Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages.
Marques-da-Silva C; Burnstock G; Ojcius DM; Coutinho-Silva R
Immunobiology; 2011; 216(1-2):1-11. PubMed ID: 20471713
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode.
Lagarias P; Vrontaki E; Lambrinidis G; Stamatis D; Convertino M; Ortore G; Mavromoustakos T; Klotz KN; Kolocouris A
J Chem Inf Model; 2018 Apr; 58(4):794-815. PubMed ID: 29485875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]